Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?
Open Access
- 15 September 2016
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 5, 2328
Abstract
The international community has committed to ending the epidemics of HIV/AIDS, tuberculosis, malaria, and neglected tropical infections by 2030, and this bold stance deserves universal support. In this paper, we discuss whether this ambitious goal is achievable for HIV/AIDS and what is needed to further accelerate progress. The joint United Nations Program on HIV/AIDS (UNAIDS) 90-90-90 targets and the related strategy are built upon currently available health technologies that can diagnose HIV infection and suppress viral replication in all people with HIV. Nonetheless, there is much work to be done in ensuring equitable access to these HIV services for key populations and those who remain outside the rims of the traditional health services. Identifying a cure and a preventive vaccine would further help accelerate progress in ending the epidemic. Other disease control programmes could learn from the response to the HIV/AIDS epidemic.Keywords
This publication has 38 references indexed in Scilit:
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV InfectionNew England Journal of Medicine, 2015
- Overcoming Impediments to Global Implementation of Early Antiretroviral TherapyNew England Journal of Medicine, 2015
- A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in AfricaNew England Journal of Medicine, 2015
- Programmatic Implications of Acute and Early HIV InfectionThe Journal of Infectious Diseases, 2015
- Defeating AIDS—advancing global healthThe Lancet, 2015
- Daily Oral Tenofovir and Emtricitabine–Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1–Uninfected Men and WomenAnnals of Internal Medicine, 2014
- Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003–11): a national observational cohort studyThe Lancet, 2013
- Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding womenCurrent Opinion in HIV and AIDS, 2013
- Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-AnalysisPLOS Medicine, 2012
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011